SEC Comment Letter 0000000000-24-005678 to CervoMed Inc. (CRVO)
CervoMed Inc.
Date: May 16, 2024 · CIK: 0001053691 · Accession: 0000000000-24-005678
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-279343
Letter
United States securities and exchange commission logo May 16, 2024 John Alam, M.D. Chief Executive Officer CervoMed Inc. 20 Park Plaza, Suite 424 Boston, MA 02116 Re:CervoMed Inc. Registration Statement on Form S-1 Filed May 10, 2024 File No. 333-279343 Dear John Alam: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jason McCaffrey, Esq.
Show Raw Text
United States securities and exchange commission logo
May 16, 2024
John Alam, M.D.
Chief Executive Officer
CervoMed Inc.
20 Park Plaza, Suite 424
Boston, MA 02116
Re:CervoMed Inc.
Registration Statement on Form S-1
Filed May 10, 2024
File No. 333-279343
Dear John Alam:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Jason McCaffrey, Esq.